Previous Articles     Next Articles

Seroprevalance of Toxoplasma gondii Infection and Genotyping of the Isolates from Cancer Patients in Anhui,Eastern China

SHEN Qian1,WANG Lin2,FANG Qiang3,SHEN Ji-long1,ZHANG Lin-jie1 *   

  1. 1 Departments of Immunology;Department of Pathogen Biology,Anhui Medical University,Hefei 230032,China; 2 Clinical Laboratory,the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Hefei 230031,China;3 Department of Parasitology,Bengbu Medical College,Bengbu 233030,China
  • Online:2014-10-30 Published:2015-01-06

Abstract:

Objective  To investigate the seroprevalence of Toxoplasma gondii infection and identify the genotypes of T. gondii isolates from cancer patients in Anhui Province.  Methods  Three hundred and fifty-six blood samples were collected from outpatients and hospitalized cancer patients in Hefei, Anhui Province. IgG and gM antibodies specific to T gondii were determined by ELISA. The ELISA positive samples were subjected to detection of Toxoplasma DNA with PCR targeting a 529-bp repeat element of T. gondii. Genotyping of T. gondii isolates was performed using multilocus PCR-RFLP and 10 genetic markers, including 9 nuclear loci, sag1, sag2, sag3, btub, gra6, L358, pk1, c22-8, c29-2, and apico.  Results  Among 356 cancer patients, 21(5.9%) cases were found to be IgG-positive and 8(2.3%) were IgM-positive, and five of them were found to have both IgG and IgM antibodies. The total seroprevalence of Toxoplasma infection was 6.8%. Six PCR-positive samples were genotyped at 10 loci and two of them obtained all genetic markers and identified as the genotype of Chinese 1(ToxoDB#9).  Conclusion  In this study, latent and active toxoplasmosis exist in the patients with malignant tumors, and two isolates are genotyped as the type of Chinese 1(ToxoDB#9) in Anhui, China.

Key words: Cancer, Toxoplasma gondii, Genotyping